GRCEHIGH SIGNALREGULATORY10-K

GRCE completed a major corporate restructuring, reincorporating from Quebec, Canada to Delaware while substantially reducing total liabilities and changing its share structure.

The reincorporation from Canada to Delaware represents a fundamental corporate transformation that typically signals a company's intention to align more closely with U.S. capital markets and governance standards. The concurrent 47% increase in outstanding shares (from 9.4M to 13.8M) and change from no-par to $0.0001 par value shares suggests significant equity restructuring or potential financing activity that investors should investigate further.

Comparing 2025-06-23 vs 2024-06-21View on EDGAR →
FINANCIAL ANALYSIS

The company's financial position shows mixed signals with total liabilities declining meaningfully by 53% to $5.4M, indicating debt reduction or restructuring benefits. However, operating performance deteriorated with operating losses expanding and operating cash flow declining by approximately 21%. While net losses narrowed modestly, the overall picture reflects a company undergoing significant structural changes while still burning cash and struggling with operational profitability.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
-53.4%
$11.6M$5.4M

Liabilities reduced 53.4% — deleveraging improves balance sheet strength and financial flexibility.

Operating Income
P&L
-29.8%
-$12.9M-$16.7M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Net Income
P&L
+25.6%
-$12.9M-$9.6M

Net income grew 25.6% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-20.8%
-$12.3M-$14.9M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Current Liabilities
Balance Sheet
+14.6%
$1.7M$1.9M

Current liabilities rose 14.6% — increased short-term obligations, watch current ratio.

LANGUAGE CHANGES
NEW — 2025-06-23
PRIOR — 2024-06-21
ADDED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
(Exact name of registrant as specified in its charter) State of Delaware 98-1359336 (State or other jurisdiction of incorporation or organization) (I.R.S.
The number of outstanding shares of common stock of the registrant, par value $0.0001 per share, as of June 19, 2025, was 13,828,562 .
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 54 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operation 55 Item 7A.
+7 more — sign up free →
REMOVED
(Exact name of registrant as specified in its charter) Qu bec, Canada 98-1359336 (State or other jurisdiction of incorporation or organization) (I.R.S.
The number of outstanding common shares of the registrant, no par value per share, as of June 21, 2024 , was 9,399,404 .
Auditor Firm Id: 185 Auditor Name: KPMG LLP Auditor Location: Philadelphia, Pennsylvania, United States Former Auditor Firm Id: 1263 Auditor Name: Ernst Young LLP Auditor Location: Montr al, QC, Canada ACASTI PHARMA INC.
Market for Registrant s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 48 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operation 54 Item 7A .
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →